Novel aldose reductase inhibitors: a patent survey (2006–present)
M Chatzopoulou, P Alexiou… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: Initially studied for its central role in the pathogenesis of chronic diabetic
complications, aldose reductase (ALR2) gains more attention over the years as its …
complications, aldose reductase (ALR2) gains more attention over the years as its …
Novel aldose reductase inhibitors: a patent survey (2006--present).
M Chatzopoulou, P Alexiou… - Expert Opinion on …, 2012 - europepmc.org
Initially studied for its central role in the pathogenesis of chronic diabetic complications,
aldose reductase (ALR2) gains more attention over the years as its implication in …
aldose reductase (ALR2) gains more attention over the years as its implication in …
[PDF][PDF] Novel aldose reductase inhibitors: a patent survey (2006--present)
M Chatzopoulou, P Alexiou, E Kotsampasakou… - researchgate.net
Introduction: Initially studied for its central role in the pathogenesis of chronic diabetic
complications, aldose reductase (ALR2) gains more attention over the years as its …
complications, aldose reductase (ALR2) gains more attention over the years as its …
Novel aldose reductase inhibitors: a patent survey (2006--present)
M Chatzopoulou, P Alexiou… - Expert opinion on …, 2012 - pubmed.ncbi.nlm.nih.gov
Introduction Initially studied for its central role in the pathogenesis of chronic diabetic
complications, aldose reductase (ALR2) gains more attention over the years as its …
complications, aldose reductase (ALR2) gains more attention over the years as its …
[PDF][PDF] Novel aldose reductase inhibitors: a patent survey (2006--present)
M Chatzopoulou, P Alexiou, E Kotsampasakou… - academia.edu
Introduction: Initially studied for its central role in the pathogenesis of chronic diabetic
complications, aldose reductase (ALR2) gains more attention over the years as its …
complications, aldose reductase (ALR2) gains more attention over the years as its …
[引用][C] Novel aldose reductase inhibitors: a patent survey (2006–present)
M Chatzopoulou, P Alexiou, E Kotsampasakou… - Expert Opinion on …, 2012 - cir.nii.ac.jp
Novel aldose reductase inhibitors: a patent survey (2006 – present) | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
[引用][C] Novel aldose reductase inhibitors: A patent survey (2006 present)
M Chatzopoulou, P Alexiou, E Kotsampasakou… - 2012 - gaia.aua.gr
Novel aldose reductase inhibitors: A patent survey (2006 present) HEAL DSpace Novel
aldose reductase inhibitors: A patent survey (2006 present) Αποθετήριο DSpace/Manakin …
aldose reductase inhibitors: A patent survey (2006 present) Αποθετήριο DSpace/Manakin …
[PDF][PDF] Novel aldose reductase inhibitors: a patent survey (2006--present)
M Chatzopoulou, P Alexiou, E Kotsampasakou… - academia.edu
Introduction: Initially studied for its central role in the pathogenesis of chronic diabetic
complications, aldose reductase (ALR2) gains more attention over the years as its …
complications, aldose reductase (ALR2) gains more attention over the years as its …